Mp77-12 Head-To-Head Comparison of Commonly Used International Prostate Cancer Risk Calculators for Prostate Biopsy

Journal of Urology- Netherlands

doi 10.1016/j.juro.2017.02.2120

Full Text

Abstract

Available in

Categories

Urology

Date

Authors

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Head-To-Head Comparison of Prostate Cancer Risk Calculators Predicting Biopsy Outcome

Translational Andrology and Urology
Reproductive MedicineUrology
2018English

Importance of Prostate Volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) Risk Calculators: Results From the Prostate Biopsy Collaborative Group

World Journal of Urology
Urology
2011English

Prospective Multi-Institutional Study Evaluating the Performance of Prostate Cancer Risk Calculators

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Is a Negative Prostate Biopsy a Risk Factor for a Prostate Cancer Related Death?

The Lancet Oncology
Oncology
2017English

Head-To-Head Comparison Of68Ga-Psma-11 PET/CT And18F-Fluciclovine PET/CT in a Case Series of 10 Patients With Prostate Cancer Recurrence

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

Risk Factors Affecting Complications Due to Prostate Biopsy

The Bulletin of Urooncology
2019English

Comparison Between Transrectal and Transperineal Prostate Biopsy for Detection of Prostate Cancer: A Meta-Analysis and Trial Sequential Analysis

Oncotarget
Oncology
2017English

Magnetic Resonance Imaging for Predicting Prostate Biopsy Findings in Patients Considered for Active Surveillance of Clinically Low Risk Prostate Cancer

Journal of Urology
Urology
2012English

SU-E-T-38: A Head to Head Comparison of Two Commercial Phantoms Used for SRS QA

Medical Physics
MedicineNuclear MedicineRadiologyImagingBiophysics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy